• 90 Seconds With Recce Pharmaceuticals

    In this quick-fire style interview with the Executive Director, Michele Dilizia, Spark Plus discusses about the company, recent positive results for RECCE 327 in MRSA Burns Wound Infection, as well as the investors’ reception about the company.
    Watch
  • 214 < Discover more events
    Interested in the ASX listed companies in this event? Check out the latest news, announcements, financial data, and capital raise history for: